Immunopotentiation of Hepatitis B Vaccine Using Biodegradable Polymers as an Adjuvant

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 4, 2010, Pages 265-270

  Sivakumar, Sivagurunathan Moni ^a   Sukumaran, Natarajapillai ^b   Nirmala, Loganathan ^c   Swarnalakshmi, Rathinavel ^c   Anilbabu, Botta ^c   Siva, Lakshmanan ^c   Anbu, Jayaraman ^c   Shanmugarajan, Thukani Sathanantham ^c   Ravichandran, Velayudam ^c  

^a Kamla Nehru College of Pharmacy   (India)

^b MANONMANIAM SUNDARANAR UNIVERSITY   (India)

^c VELS INSTITUTE OF SCIENCE   (India)

Author keywords

Adjuvant; Biodegradable polymers; Hepatitis B vaccine; Vaccine delivery system

Indexed keywords

CHITOSAN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOLOGICAL ADJUVANT; POLYGLACTIN; POLYLACTIC ACID; DELAYED RELEASE FORMULATION; GLYCOLIC ACID DERIVATIVE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPOTENTIATION; IN VITRO STUDY; MICROENCAPSULATION; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; VACCINE PRODUCTION; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; DELAYED RELEASE FORMULATION; IMMUNOLOGY; PHARMACOKINETICS; WISTAR RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHITOSAN; DELAYED-ACTION PREPARATIONS; GLYCOLATES; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; LACTIC ACID; POLYMERS; RATS; RATS, WISTAR; POLYGLYCOLIC ACID;

EID: 77955318500     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60042-4     Document Type: Article

References (14)

1. Kane MA Global status of hepatitis B immunization. Lancet 1996, 348:696.
2. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, Spengler U Imbalanced intra hepatic expression of interleukin 12, interferon gamma and interleukin 10 in fulminant hepatitis B. Hepatology 2002, 36:1001-1008.
3. Chunsttiwat S, Ann Bigs B, Maynard JE, Thammapormpilas P, O-Prasertsawat M Comparative evaluation of DTP-HB vaccine in the EPI in Chiangrai province, Thailand. Vaccine 2002, 21:188-193.
4. Hanes J, Cleland JL, Langer R New advances in microsphere based single dose vaccine. Adv Drug Deliv Rev 1997, 28:97-119.
5. Sesardic D, Dobbelaer R European Union regulatory development for new vaccine adjuvants and delivery systems. Vaccine 2004, 22:2452-2456.
6. Sanchez A, Villamayor B, Guo Y, McIver J, Alonso MJ Formulation strategies for the stabilization of tetanus toxoid in poly (lactide-co-glycolide) microspheres. Int J Pharm 1999, 185:255-266.
7. Lowry OH, Rosebrough NJ, Farr AL Protein measurement with folin phenol reagent. J Biol Chem 1951, 193:265-275.
8. Aguado MT, Lambert PH Controlled release vaccines biodegradable poly lactide/poly glycolide (PL/PG) microspheres as antigen vehicles. Immunobiology 1992, 184:113-125.
9. Cleland JL, Barron L, Berman PW, Daugherty A, Gregory T, Lim A, et al. Development of a single shot sub unit vaccine for HIV-1:2. Defining optimal auto boost characteristics the humoral immune response. J Pharm Sci 1996, 85:1346-1349.
10. Men Y, Gander B, Merkle HP, Corradin G Induction of sustained and elevated immune responses to weekly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine 1996, 14:1442-1450.
11. Jiang W, Rajesh Gupta K, Mangesh Deshpande C, Steven Schwendeman P Biodegradable poly (lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 2005, 57:391-410.
12. Hanes J, Cleland JL, Langer R New advances in microsphere based single dose vaccine. Adv Drug Del Rev 1997, 28:97-119.
13. Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR Chronic local tissue reactions, long term immunogenicity and immunologic priming of mice guinea pigs to tetanus toxoid en capsulated in biodegradable polymer microspheres composed of poly lactide- co-glycolide polymers. Vaccine 1997, 15:1716-1723.
14. Panyam J, Dalis MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, et al. Polymer degradation and in vitro release of a model protein from poly (D,L-lactide-co-glycolide) nano and microparticles. J Control Release 2003, 92:173-187.